Targeted wound care Potential customers include healthcare facilities and clinics that manage chronic and acute wounds, such as long-term care centers, wound care clinics, and surgical centers, where CIP system can offer a less invasive alternative to surgical debridement.

Biofilm solution Highlight CIP’s ability to remove biofilm and necrotic material to accelerate healing, positioning the product for facilities facing costly readmissions or poor wound healing rates due to biofilm contamination.

Low-resource appeal Emphasize cost and resource efficiencies: eliminates need for operating rooms, anesthesia, or specialized treatment rooms, making it attractive to budget-conscious hospitals, ambulatory surgery centers, and home health providers.

Adjacent markets Explore opportunities in infection control and post-surgical care across acute care, long-term care, and home health segments, where MRSA and contaminated wounds are common concerns.

Growth channels Leverage digital tools and partnerships with wound care distributors, medical device reps, and clinics; use Calendly and Squarespace presence to coordinate demonstrations and trials for rapid validation.